<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03350503</url>
  </required_header>
  <id_info>
    <org_study_id>ILV814-P001</org_study_id>
    <nct_id>NCT03350503</nct_id>
  </id_info>
  <brief_title>AcrySof Toric IQ Post-Market Clinical Study</brief_title>
  <official_title>AcrySof Toric IQ A-Code Post-Market Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to clinically confirm the rotational stability of a modified
      AcrySof IQ toric intraocular lens (IOL) in a Japanese population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye
      will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in
      which the IOL is implanted first will be selected as the target eye.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with absolute value of IOL rotation of less than 10 degrees at Visit 4 from Visit 00</measure>
    <time_frame>Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)</time_frame>
    <description>IOL rotation is defined as the IOL axis difference between study visits. A photograph of the eye will be taken, and IOL rotation will be calculated as the angle between the toric mark on the IOL at Visit 4 and the reference point from Visit 00 (minimum 0 degrees, maximum 180 degrees). A lower value indicates greater IOL stability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with absolute value of IOL rotation of less than 20 degrees at Visit 4 from Visit 00</measure>
    <time_frame>Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with absolute value of IOL rotation of less than 30 degrees at Visit 4 from Visit 00</measure>
    <time_frame>Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cataract</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Acrysof IQ Toric A-code IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IOL implanted during cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof IQ Toric A-code IOL</intervention_name>
    <description>Intended to provide visual acuity, including astigmatism correction, over the lifetime of the cataract patient</description>
    <arm_group_label>Acrysof IQ Toric A-code IOL</arm_group_label>
    <other_name>Models SN6AT3, SN6AT4, SN6AT5</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cataract surgery</intervention_name>
    <description>Removal of cataractous lens and implantation of IOL</description>
    <arm_group_label>Acrysof IQ Toric A-code IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of cataracts with planned cataract removal by phacoemulsification

          -  Calculated lens power within the available range

          -  Able to sign informed consent and complete all study visits

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Eye conditions as specified in the protocol

          -  Uncontrolled glaucoma

          -  Pregnancy, current or planned

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alcon Japan, Ltd.</last_name>
    <phone>+81.3.6899.5061</phone>
    <email>alcon.medinfo@alcon.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Hiroshima</city>
        <state>Hiroshima Prefecture</state>
        <zip>733-0842</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Hakodate</city>
        <state>Hokkaido</state>
        <zip>040-0053</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Miyakonoj≈ç</city>
        <state>Miyazaki Prefecture</state>
        <zip>885-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Saga</city>
        <state>Saga Prefecture</state>
        <zip>840-0831</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2017</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>phacoemulsification</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>vision</keyword>
  <keyword>toric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

